RxDoctor Payments Data

Ahmad Alawneh, MD

Family Medicine · Oregon, OHNPI 1659834778

Payments from drug & device makers

$797in general payments, 2019–2025

Across 45 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$106
  • Exact Sciences$102
  • Novo Nordisk$91
  • Pfizer$90
  • Boehringer Ingelheim$51
  • Novartis$46
  • plus $311 from 13 others

What the payments were for

  • Food & beverage$797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$797 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$89,349
Medicare patients
206
Services billed
1,130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide70$101,980
EliquisApixaban82$82,783
Trelegy ElliptaFluticasone/Umeclidin/Vilanter113$79,954
OzempicSemaglutide65$78,961
JardianceEmpagliflozin41$50,753
TrulicityDulaglutide40$48,527
JanuviaSitagliptin Phosphate39$43,024
VraylarCariprazine Hcl11$42,279
FarxigaDapagliflozin Propanediol32$37,077
XareltoRivaroxaban28$32,966
Janumet XrSitagliptin Phos/Metformin Hcl20$30,836
GemtesaVibegron23$16,312
EntrestoSacubitril/Valsartan19$16,023
MyrbetriqMirabegron19$14,477
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$14,090

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$90$82,78382 claims
GSKTrelegy Ellipta$33$79,954113 claims
Novo NordiskOzempic$91$78,96165 claims
MerckJanuvia, Janumet Xr$38$73,86059 claims
Boehringer IngelheimJardiance, Stiolto Respimat$51$59,98759 claims
AbbVieVraylar$106$42,27911 claims
Johnson & JohnsonXarelto$14$32,96628 claims
Sumitomo Pharma America, Inc.Gemtesa$33$16,31223 claims
NovartisEntresto$46$16,02319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Oregon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →